Table 3.

IFIPT scores at baseline, 1-week, and 1-year follow-up in aMCI and NC participants

IFIPT variables	Baseline, mean (SD), range		One-week follow-up, mean (SD), range		One-year follow-up, mean (SD), range
	aMCI (n = 36)	NC (n = 111)	aMCI (n = 34)	NC (n = 113)	aMCI (n = 21)	NC (n = 92)
Trial 1 correct	11.94 (2.03), 9–16	12.11 (2.09), 7–18	14.44* (2.61), 8–20	15.47(2.58), 9–20	12.57** (2.11), 9–16	14.54 (2.71), 8–20
Trial 1 hits	1.75 (1.52), 0–5	2.21 (1.63), 0–7	4.00* (2.56), 0–9	5.10 (2.45), 0–10	2.24 (1.64), 0–5	2.97 (1.85), 0–8
Trial 1 false positives	9.69 (3.64), 4–20	9.49 (3.49), 2–18	8.71* (3.59), 1–17	7.32 (3.43), 0–17	10.33* (4.26), 3–19	8.64 (2.87), 2–17
Trial 3 correct	16.06* (2.11), 11–20	16.54 (2.52), 9–20	16.71 (2.46), 10–20	17.57 (2.18), 10–20	16.10** (2.86), 9–20	17.82 (2.40), 10–20
Trial 3 hits	3.89** (2.38), 0–9	5.30 (2.07), 1–10	5.21*** (2.35), 1–9	6.88 (2.25), 1–10	3.95*** (2.27), 0–7	6.21 (2.25), 1–10
Trial 3 false positives	7.22* (3.34), 1–13	5.83 (3.23), 0–14	6.44** (3.65), 1–15	4.32 (3.65), 0–19	6.90** (4.17), 0–16	4.46 (3.62), 0–18
Total learning	5.64** (3.52), 1–14	7.59 (3.09), 1–16	9.21** (4.62), 2–18	12.01 (4.27), 2–20	6.19** (3.70), 0–12	9.21 (3.59), 2–18
Recognition delay correct	14.80* (2.43), 9–20	15.92 (2.52), 9–20	15.29** (2.53), 10–20	16.88 (2.35), 9–20	15.20** (2.63), 10–19	17.01 (2.23), 11–20
Recognition delay hits	3.40* (2.19), 1–9	4.33 (2.16), 0–9	4.74** (2.25), 1–9	6.26 (2.44), 0–10	3.55** (2.46), 0–8	5.41 (2.21), 0–9
Recognition delay false positives	7.80 (3.22), 2–14	6.84 (3.29), 0–17	7.74** (3.16), 1–13	5.46 (3.55), 0–19	8.15** (4.78), 1–20	5.56 (3.40), 0–15

Notes: IFIPT hits are out of 10 possible points. IFIPT = Indiana faces in places test; aMCI = amnestic mild cognitive impairment; NC = normal comparison.

*T-tests significant at p < .05.

**T-tests significant at p < .01.

***T-tests significant at p < .001.